These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


419 related items for PubMed ID: 11420459

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia.
    Riethdorf L, Riethdorf S, Lee KR, Cviko A, Löning T, Crum CP.
    Hum Pathol; 2002 Sep; 33(9):899-904. PubMed ID: 12378514
    [Abstract] [Full Text] [Related]

  • 4. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
    Walts AE, Lechago J, Bose S.
    Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
    [Abstract] [Full Text] [Related]

  • 5. TOP2A/MCM2, p16INK4a, and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesions.
    Del Moral-Hernández O, Hernández-Sotelo D, Alarcón-Romero LDC, Mendoza-Catalán MA, Flores-Alfaro E, Castro-Coronel Y, Ortiz-Ortiz J, Leyva-Vázquez MA, Ortuño-Pineda C, Castro-Mora W, Illades-Aguiar B.
    BMC Cancer; 2021 Jan 07; 21(1):39. PubMed ID: 33413211
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CIN grades possessing different HPV RNA location patterns and RNAscope is helpful tool for distinguishing squamous intraepithelial lesions in difficult cervical cases.
    Chen R, Zhang R, Zhang M, Liu S, Xie M, Yang Z, Shi Q, Chen H, Xiong H, Wang N, Jiang Q.
    Diagn Pathol; 2023 Feb 16; 18(1):23. PubMed ID: 36797728
    [Abstract] [Full Text] [Related]

  • 8. P16/CDKN2A and Ki-67 enhance the detection of anal intraepithelial neoplasia and condyloma and correlate with human papillomavirus detection by polymerase chain reaction.
    Pirog EC, Quint KD, Yantiss RK.
    Am J Surg Pathol; 2010 Oct 16; 34(10):1449-55. PubMed ID: 20871219
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.
    Yildiz IZ, Usubütün A, Firat P, Ayhan A, Küçükali T.
    Pathol Res Pract; 2007 Oct 16; 203(6):445-9. PubMed ID: 17543474
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunohistochemistry and in situ hybridization for the diagnosis and classification of squamous lesions of the anogenital region.
    Pirog EC.
    Semin Diagn Pathol; 2015 Sep 16; 32(5):409-18. PubMed ID: 25862555
    [Abstract] [Full Text] [Related]

  • 17. Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis.
    Qiao X, Bhuiya TA, Spitzer M.
    J Low Genit Tract Dis; 2005 Apr 16; 9(2):100-7. PubMed ID: 15870531
    [Abstract] [Full Text] [Related]

  • 18. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests.
    Toll AD, Kelly D, Maleki Z.
    Diagn Cytopathol; 2014 Jul 16; 42(7):576-81. PubMed ID: 24288264
    [Abstract] [Full Text] [Related]

  • 19. Utility of Human Papillomavirus Capsid Protein L1 and p16 in the Assessment and Accurate Classification of Anal Squamous Intraepithelial Lesions.
    Patil DT, Yang B.
    Am J Clin Pathol; 2015 Jul 16; 144(1):113-21. PubMed ID: 26071469
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.